Works by Kim, Sang Soo


Results: 206
    1
    2
    3
    4
    5
    6

    A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1800, doi. 10.1111/dom.14766
    By:
    • Ryang, Soree;
    • Kim, Sang Soo;
    • Bae, Ji Cheol;
    • Han, Ji Min;
    • Kwon, Su Kyoung;
    • Kim, Young Il;
    • Nam‐Goong, Il Seong;
    • Kim, Eun Sook;
    • Kim, Mi‐kyung;
    • Lee, Chang Won;
    • Yoo, Soyeon;
    • Koh, Gwanpyo;
    • Kwon, Min Jeong;
    • Park, Jeong Hyun;
    • Kim, In Joo
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

    Published in:
    Endocrinology & Metabolism, 2024, v. 39, n. 5, p. 722, doi. 10.3803/EnM.2024.1995
    By:
    • Nam Hoon Kim;
    • Juneyoung Lee;
    • Suk Chon;
    • Jae Myung Yu;
    • In-Kyung Jeong;
    • Soo Lim;
    • Won Jun Kim;
    • Keeho Song;
    • Ho Chan Cho;
    • Hea Min Yu;
    • Kyoung-Ah Kim;
    • Sang Soo Kim;
    • Soon Hee Lee;
    • Chong Hwa Kim;
    • Soo Heon Kwak;
    • Yong‐ho Lee;
    • Choon Hee Chung;
    • Sihoon Lee;
    • Heung Yong Jin;
    • Jae Hyuk Lee
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 818, doi. 10.4093/dmj.2023.0171
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Sang Soo Kim;
    • Hye Soon Kim;
    • Nam Hoon Kim;
    • Sin Gon Kim;
    • Seung Hyun Ko;
    • Ji Hyun Lee;
    • Inkyu Lee;
    • Bo Kyeong Lee;
    • Kyu Chang Won
    Publication type:
    Article
    31

    Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.

    Published in:
    Diabetes & Metabolism Journal, 2022, v. 46, n. 3, p. 464, doi. 10.4093/dmj.2021.0088
    By:
    • Soo Jin Yun;
    • In-Kyung Jeong;
    • Jin-Hye Cha;
    • Juneyoung Lee;
    • Ho Chan Cho;
    • Sung Hee Choi;
    • SungWan Chun;
    • Hyun Jeong Jeon;
    • Ho-Cheol Kang;
    • Sang Soo Kim;
    • Seung-Hyun Ko;
    • Gwanpyo Koh;
    • Su Kyoung Kwon;
    • Jae Hyuk Lee;
    • Min Kyong Moon;
    • Junghyun Noh;
    • Cheol-Young Park;
    • Sungrae Kim
    Publication type:
    Article
    32
    33

    Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study.

    Published in:
    Diabetes & Metabolism Journal, 2021, v. 45, n. 5, p. 675, doi. 10.4093/dmj.2020.0107
    By:
    • Jun Sung Moon;
    • Sunghwan Suh;
    • Sang Soo Kim;
    • Heung Yong Jin;
    • Jeong Mi Kim;
    • Min Hee Jang;
    • Kyung Ae Lee;
    • Ju Hyung Lee;
    • Seung Min Chung;
    • Young Sang Lyu;
    • Jin Hwa Kim;
    • Sang Yong Kim;
    • Jung Eun Jang;
    • Tae Nyun Kim;
    • Sung Woo Kim;
    • Eonju Jeon;
    • Nan Hee Cho;
    • Mi-Kyung Kim;
    • Hye Soon Kim;
    • Il Seong Nam-Goong
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50